Loading: 100%
Lilly (Eli) & Co. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter Indianapolis, United States of AmericaIndianapolis, United States of Americano data available
Employees 41,975 (as per Q1 2017)no data available
Sector Drug Manufacturers, HealthcareDrug Manufacturers, Healthcareno data available
Ticker LLYno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1760,067,575,082,590,0
datesClosing price (adj.)
13.10.201786.55
11.10.201786.06
04.10.201786.96
27.09.201784.65
20.09.201782.02
13.09.201782.43
06.09.201780.51
30.08.201780.49
23.08.201778.15
16.08.201780.69
09.08.201782.04
02.08.201781.30
26.07.201781.32
19.07.201783.69
12.07.201782.97
05.07.201782.17
27.06.201782.51
20.06.201782.22
13.06.201780.73
06.06.201778.59
30.05.201777.85
23.05.201777.49
16.05.201778.49
09.05.201779.76
02.05.201780.66
25.04.201780.16
18.04.201780.16
11.04.201784.83
04.04.201784.99
28.03.201783.67
21.03.201782.66
14.03.201783.38
07.03.201781.68
28.02.201781.75
21.02.201779.33
14.02.201777.80
07.02.201776.20
31.01.201775.54
24.01.201773.40
17.01.201775.36
10.01.201774.80
03.01.201773.16
27.12.201672.38
19.12.201672.00
12.12.201666.30
05.12.201665.96
28.11.201665.90
21.11.201675.16
14.11.201675.53
07.11.201671.98
31.10.201671.94
24.10.201675.58
17.10.201676.51
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
86.55n/a
Market Capitalisation
in million USD
95,498n/a
Enterprise Value
in million USD
99,838n/a
Common Shares Outstanding
as per Apr 24, 2017
1,103,388,743n/a
Preferred Shares Outstanding
as per Apr 24, 2017
n/a
Average Basic Shares Outstanding
TTM
1,057,424,000n/a
Average Diluted Shares Outstanding
TTM
1,060,125,000n/a
Index Membership
n/a
Business Summary
Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.
no data available
Key Financials & Ratios (all figures TTM as per Dec 31, 2016, million USD, full statements further below)
Profit & Loss
Revenues 21,222n/a
Gross Profit 15,567n/a
Operating Income 3,871n/a
EBITDA 5,368n/a
Net Profit 2,738n/a
Balance Sheet
Cash and Cash Equivalents 6,039n/a
Receivables 4,029n/a
Total Current Assets 15,101n/a
PP&E 8,253n/a
Total Assets 38,806n/a
Accounts Payable 1,349n/a
Current Debt 1,937n/a
Total Current Liabilities 10,987n/a
Long-Term Debt 8,368n/a
Total Liabilities 24,725n/a
Total Equity 14,081n/a
Cash Flow
Depreciation & Amortisation 1,497n/a
Change in Working Capital -484n/a
Operating Cash Flow 4,851n/a
Net Change in PP&E and Intangibles -1,019n/a
Investing Cash Flow -3,139n/a
Dividends Paid -2,159n/a
Financing Cash Flow -560n/a
Total Change in Cash 916n/a
Free Cash Flow 3,229n/a
Profitability Ratios
Gross Margin 73.4%n/a
Operating Margin 18.2%n/a
Net Profit Margin 12.9%n/a
Return on Equity 19.4%n/a
Return on Assets 7.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA 18.60n/a
EV/Sales 4.70n/a
Book to Market Value 0.15n/a
Other Ratios
Current Ratio 137.5%n/a
Liabilities to Equity Ratio 175.6%n/a
Debt to Assets Ratio 26.6%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
18,634
20,372
21,836
23,076
24,287
22,603
23,113
19,616
19,959
21,222
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
0
Cost of revenue
-4,249
-4,377
-4,247
-4,366
-5,068
-4,797
-4,908
-4,933
-5,037
-5,655
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
14,385
15,995
17,589
18,710
19,219
17,807
18,205
14,683
14,922
15,567
Other Operating Income
0
0
0
0
0
0
0
0
0
0
Operating Expenses
-9,582
-10,467
-11,219
-11,938
-12,901
-12,792
-12,657
-11,354
-11,329
-11,696
Selling, General & Administrative
-6,095
-6,626
-6,893
-7,053
-7,880
-7,514
-7,126
-6,621
-6,533
-6,452
Selling & Marketing
0
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
0
Research & Development
-3,487
-3,841
-4,327
-4,884
-5,021
-5,278
-5,531
-4,734
-4,796
-5,244
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
4,803
5,528
6,370
6,772
6,318
5,015
5,548
3,329
3,592
3,871
Non-Operating Income (Loss)
122
-26
-230
-5
-179
674
519
341
101
-85
Interest Expense, net
0
0
0
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
122
-26
-230
-5
-179
674
519
341
101
-85
Pretax Income (Loss), Adjusted
4,925
5,502
6,141
6,767
6,139
5,689
6,067
3,669
3,693
3,787
Abnormal Gains (Losses)
-1,048
-6,809
-783
-242
-789
-281
-178
-669
-903
-413
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
3,877
-1,308
5,358
6,525
5,350
5,408
5,889
3,000
2,790
3,374
Income Tax (Expense) Benefit, net
-924
-764
-1,029
-1,456
-1,002
-1,320
-1,205
-610
-382
-636
Current Income Tax
0
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
2,953
-2,072
4,329
5,070
4,348
4,089
4,685
2,391
2,408
2,738
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
2,953
-2,072
4,329
5,070
4,348
4,089
4,685
2,391
2,408
2,738
Minority Interest
0
0
0
0
0
0
0
0
0
0
Net Income
2,953
-2,072
4,329
5,070
4,348
4,089
4,685
2,391
2,408
2,738
Preferred Dividends
0
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
2,953
-2,072
4,329
5,070
4,348
4,089
4,685
2,391
2,408
2,738
Remarks
restated on Feb 22, 2010 n/a
calculated values,
restated on Feb 22, 2011 n/a
calculated values,
restated on Feb 24, 2012 n/a
calculated values,
restated on Feb 21, 2013 n/a
calculated values,
restated on Feb 19, 2014 n/a
calculated values,
restated on Feb 19, 2015 n/a
calculated values,
restated on Feb 19, 2016 n/a
calculated values,
restated on Feb 21, 2017 n/a
calculated values,
restated on Feb 21, 2017 n/a
calculated values,
restated on Feb 21, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
5,926
4,498
6,727
6,897
5,684
5,397
4,827
4,452
6,039
Cash & Cash Equivalents
n/a
5,497
4,463
5,993
5,923
4,019
3,830
3,872
3,666
4,582
Short Term Investments
n/a
429
35
734
975
1,666
1,567
955
785
1,457
Accounts & Notes Receivable
n/a
2,779
3,343
3,494
3,598
3,336
3,434
3,235
3,513
4,029
Accounts Receivable, Net
n/a
2,779
3,343
3,494
3,598
3,336
3,434
3,235
3,513
4,029
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
0
Inventories
n/a
2,493
2,850
2,518
2,300
2,644
2,929
2,740
3,446
3,562
Raw Materials
n/a
0
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
1,255
1,796
2,102
1,454
1,374
1,344
1,127
1,163
1,472
Prepaid Expenses
n/a
375
1,307
1,437
813
822
756
560
604
735
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
382
0
0
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
499
489
664
640
552
588
567
559
737
Total Current Assets
n/a
12,453
12,487
14,840
14,248
13,039
13,105
11,928
12,574
15,101
Property, Plant & Equipment, Net
n/a
8,626
8,197
7,941
7,760
7,760
7,976
7,964
8,054
8,253
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
1,545
1,156
1,780
4,030
6,314
7,625
4,569
3,647
5,208
Long Term Investments
n/a
0
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
6,588
5,621
6,441
7,622
7,286
6,544
11,847
11,295
10,244
Intangible Assets
n/a
3,929
3,700
4,819
5,128
4,753
0
0
0
0
Goodwill
n/a
0
0
0
0
0
1,517
1,758
4,040
3,973
Other Intangible Assets
n/a
0
0
0
0
0
2,814
2,884
5,035
4,358
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
2,659
1,921
1,622
2,493
2,533
2,213
7,204
2,221
1,914
Total Noncurrent Assets
n/a
16,759
14,974
16,161
19,412
21,360
22,144
24,379
22,995
23,705
Total Assets
n/a
29,213
27,461
31,001
33,660
34,399
35,249
36,308
35,569
38,806
Liabilities and owners' equity
Payables & Accruals
n/a
1,652 1651800000
1,853 1852800000
2,070 2069700000
1,929 1929100000
1,873 1873200000
1,897 1897200000
1,752 1751900000
2,236 2236100000
2,017 2016500000
Accounts Payable
n/a
886 885800000
968 968100000
1,072 1072200000
1,125 1125200000
1,188 1188300000
1,119 1119300000
1,128 1128100000
1,338 1338200000
1,349 1349300000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
537 536800000
538 538000000
540 540000000
542 542300000
541 541400000
524 523500000
530 530300000
539 539000000
548 548100000
Other Payables & Accruals
n/a
229 229200000
347 346700000
458 457500000
262 261600000
144 143500000
254 254400000
94 93500000
359 358900000
119 119100000
Short Term Debt
n/a
5,846 5846300000
27 27400000
156 156000000
1,522 1522300000
12 11900000
1,013 1012600000
2,689 2688700000
6 6100000
1,937 1937400000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
5,686 5686300000
4,688 4687900000
4,701 4701200000
5,480 5479500000
6,504 6504400000
6,007 6006800000
5,300 5300400000
5,987 5987400000
7,033 7032700000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
75 74700000
0 0
0 0
422 422300000
1,048 1048000000
793 792800000
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
5,612 5611600000
4,688 4687900000
4,701 4701200000
5,057 5057200000
5,456 5456400000
5,214 5214000000
5,300 5300400000
5,987 5987400000
7,033 7032700000
Total Current Liabilities
n/a
13,184 13184400000
6,568 6568100000
6,927 6926900000
8,931 8930900000
8,390 8389500000
8,917 8916600000
9,741 9741000000
8,230 8229600000
10,987 10986600000
Long Term Debt
n/a
4,616 4615700000
6,635 6634700000
6,771 6770500000
5,465 5464700000
5,519 5519400000
4,200 4200300000
5,333 5332800000
7,972 7972400000
8,368 8367800000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
4,675 4674800000
4,733 4732800000
4,891 4891200000
5,729 5728600000
5,716 5716100000
4,491 4491100000
5,846 5845700000
4,777 4776600000
5,371 5371000000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
2,388 2387600000
2,335 2334700000
1,887 1887400000
3,069 3068500000
3,012 3012400000
1,549 1549400000
2,563 2562900000
2,160 2160300000
2,454 2453900000
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
2,287 2287200000
2,398 2398100000
3,004 3003800000
2,660 2660100000
2,704 2703700000
2,942 2941700000
3,283 3282800000
2,616 2616300000
2,917 2917100000
Total Noncurrent Liabilities
n/a
9,291 9290500000
11,368 11367500000
11,662 11661700000
11,193 11193300000
11,236 11235500000
8,691 8691400000
11,179 11178500000
12,749 12749000000
13,739 13738800000
Total Liabilities
n/a
22,475 22474900000
17,936 17935600000
18,589 18588600000
20,124 20124200000
19,625 19625000000
17,608 17608000000
20,920 20919500000
20,979 20978600000
24,725 24725400000
Preferred Equity
n/a
-86 -86300000
-77 -77400000
-52 -52400000
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
2,053 2052700000
2,341 2341100000
2,507 2506600000
2,598 2597800000
2,667 2666500000
2,735 2735300000
2,974 2973700000
3,230 3230200000
3,316 3315900000
Common Stock
n/a
711 711100000
719 718700000
721 721300000
724 724100000
717 716600000
699 698500000
695 694600000
691 691300000
689 688500000
Additional Paid in Capital
n/a
3,977 3976600000
4,636 4635600000
4,799 4798500000
4,887 4886800000
4,963 4963100000
5,050 5050000000
5,292 5292300000
5,552 5552100000
5,641 5640600000
Other Share Capital
n/a
-2,635 -2635000000
-3,013 -3013200000
-3,013 -3013200000
-3,013 -3013100000
-3,013 -3013200000
-3,013 -3013200000
-3,013 -3013200000
-3,013 -3013200000
-3,013 -3013200000
Treasury Stock
n/a
-99 -99200000
-99 -98500000
-96 -96400000
-95 -95300000
-192 -192400000
-94 -93600000
-91 -91400000
-90 -90000000
-81 -80500000
Retained Earnings
n/a
7,655 7654900000
9,830 9830400000
12,733 12732600000
14,898 14897800000
16,088 16088200000
16,992 16992400000
16,483 16482700000
16,012 16011800000
16,046 16046300000
Other Equity
n/a
-2,787 -2786800000
-2,472 -2471900000
-2,670 -2670100000
-3,859 -3858600000
-3,797 -3797100000
-2,003 -2002700000
-3,992 -3991800000
-4,581 -4580700000
-5,274 -5274000000
Equity Before Minority Interest
n/a
6,735 6735300000
9,524 9523700000
12,420 12420300000
13,542 13541700000
14,765 14765200000
17,631 17631400000
15,373 15373200000
14,571 14571300000
14,008 14007700000
Minority Interest
n/a
2 2400000
2 1600000
-8 -7500000
-6 -6100000
9 8700000
9 9300000
15 14900000
19 19000000
73 72800000
Total Equity
n/a
6,738 6737700000
9,525 9525300000
12,413 12412800000
13,536 13535600000
14,774 14773900000
17,641 17640700000
15,388 15388100000
14,590 14590300000
14,081 14080500000
Total Liabilities & Equity
n/a
29,213 29212600000
27,461 27460900000
31,001 31001400000
33,660 33659800000
34,399 34398900000
35,249 35248700000
36,308 36307600000
35,569 35568900000
38,806 38805900000
Remarks restated on n/a restated on Feb 22, 2010 n/a restated on Feb 22, 2011 n/a restated on Feb 24, 2012 n/a restated on Feb 21, 2013 n/a restated on Feb 19, 2014 n/a restated on Feb 19, 2015 n/a restated on Feb 19, 2016 n/a restated on Feb 21, 2017 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
2,953
-2,072
4,329
5,070
4,348
4,089
4,685
2,391
2,408
2,738
Net Income
0
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
1,048
1,123
1,298
1,328
1,374
1,462
1,446
1,379
1,428
1,497
Non-Cash Items
1,207
7,321
-334
645
265
-195
-2
1,014
268
1,101
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
-54
924
-957
-186
1,248
-51
-393
-326
-1,139
-484
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
5,155
7,296
4,336
6,857
7,235
5,305
5,735
4,458
2,965
4,851
Change in Fixed Assets & Intangibles
-1,050
-922
-747
-1,112
-1,280
190
-914
-1,551
-1,124
-1,019
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
49
-815
676
-483
-2,321
-3,263
-2,807
1,207
-158
-2,260
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-2,673
-6,083
0
-609
-308
-199
-44
-551
-5,283
-45
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
0
Other Investing Activities
-654
551
215
-956
-916
440
1,692
-3,014
6,592
185
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
-4,328
-7,269
143
-3,160
-4,824
-2,833
-2,073
-3,909
27
-3,139
Dividends Paid
-1,854
-2,057
-2,152
-2,165
-2,180
-2,187
-2,121
-2,101
-2,127
-2,159
Cash From (Repayment of) Debt
985
4,411
-3,424
124
-196
-1,511
-11
2,639
-182
2,500
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
0
0
0
0
0
-721
-1,698
-800
-750
-600
Increase in Capital Stock
0
0
0
0
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
0
0
0
0
Other Financing Activities
24
-8
43
19
6
0
0
96
-53
-301
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
-845
2,346
-5,534
-2,022
-2,370
-4,420
-3,829
-166
-3,111
-560
Net Cash Before Disc. Operations and FX
-19
2,373
-1,055
1,675
40
-1,948
-167
383
-120
1,152
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
0
Net Cash Before FX
-19
2,373
-1,055
1,675
40
-1,948
-167
383
-120
1,152
Effect of Foreign Exchange Rates
130
-97
22
-145
-111
44
-22
-342
-86
-236
Net Changes in Cash
111
2,276
-1,034
1,530
-71
-1,904
-189
41
-205
916
Remarks
restated on Feb 22, 2010 n/a
calculated values,
restated on Feb 22, 2011 n/a
calculated values,
restated on Feb 24, 2012 n/a
calculated values,
restated on Feb 21, 2013 n/a
calculated values,
restated on Feb 19, 2014 n/a
calculated values,
restated on Feb 19, 2015 n/a
calculated values,
restated on Feb 19, 2016 n/a
calculated values,
restated on Feb 21, 2017 n/a
calculated values,
restated on Feb 21, 2017 n/a
calculated values,
restated on Feb 21, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo